Literature DB >> 35478118

En Bloc Resection of Solitary Brain Metastasis: The Role of Perilesional Edema.

Placido Bruzzaniti1,2, Pierfrancesco Lapolla3,4,5, Antonio Santoro1, Pietro Familiari1, Alessia D'Amico6,7, Giuseppa Zancana1, Michael Katsev1, Michela Relucenti4, Giuseppe Familiari4, Andrea Mingoli5, Giancarlo D'Andrea2, Alessandro Frati1,8, Maurizio Salvati9.   

Abstract

BACKGROUND/AIM: The treatment of solitary brain metastasis is a challenging intervention since the incidence increases and prognosis is poor. This study investigated the role of perilesional edema in the overall mass effect of solitary brain metastasis. PATIENTS AND METHODS: We conducted a retrospective analysis on 88 patients with single supratentorial brain metastasis and concomitant perilesional edema undergoing en bloc resection. Each patient was evaluated for perilesional brain edema grading. We stratified patients into three groups based on the size of the metastatic lesion and the extent of perilesional edema.
RESULTS: The grade of perilesional edema at 30 days after surgical removal did not correlate with the maximum diameter of the metastasis (Pearson's correlation 0.098, p=0.494). In patients with a maximal metastatic diameter ≤2 cm, the grade of perilesional edema before surgical treatment was 1.63 (STD 0.43), while 30 days after removal it was significantly reduced; 0.47 (STD 0.26), p<0.001.
CONCLUSION: The overall mass effect of solitary supratentorial brain metastases is not correlated to the size of the lesion and the grade of the associated perilesional edema should be considered. Surgical en bloc resection can be considered the first choice of treatment in the presence of solitary metastasis ≤2 cm in maximal diameter but with high-grade edema, since this treatment reduces the overall mass effect.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Brain metastasis; en bloc resection; overall mass effect; perilesional edema; size of lesion

Mesh:

Year:  2022        PMID: 35478118      PMCID: PMC9087063          DOI: 10.21873/invivo.12827

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  33 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).

Authors:  Paolo Tini; Valerio Nardone; Pierpaolo Pastina; Giuseppe Battaglia; Claudia Vinciguerra; Tommaso Carfagno; Giovanni Rubino; Salvatore Francesco Carbone; Lucio Sebaste; Alfonso Cerase; Antonio Federico; Luigi Pirtoli
Journal:  Neurol Sci       Date:  2017-03-04       Impact factor: 3.307

Review 3.  Brain metastases: epidemiology.

Authors:  Quinn T Ostrom; Christina Huang Wright; Jill S Barnholtz-Sloan
Journal:  Handb Clin Neurol       Date:  2018

4.  Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

Authors:  C J Vecht; A Hovestadt; H B Verbiest; J J van Vliet; W L van Putten
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

5.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

Authors:  Leo J Schouten; Joost Rutten; Hans A M Huveneers; Albert Twijnstra
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

Review 6.  Brain metastases.

Authors:  Jaime Gállego Pérez-Larraya; Jerzy Hildebrand
Journal:  Handb Clin Neurol       Date:  2014

7.  Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Authors:  Anna S Berghoff; Elisabeth Fuchs; Gerda Ricken; Bernhard Mlecnik; Gabriela Bindea; Thomas Spanberger; Monika Hackl; Georg Widhalm; Karin Dieckmann; Daniela Prayer; Amelie Bilocq; Harald Heinzl; Christoph Zielinski; Rupert Bartsch; Peter Birner; Jerome Galon; Matthias Preusser
Journal:  Oncoimmunology       Date:  2015-06-09       Impact factor: 8.110

Review 8.  Current approaches to the management of brain metastases.

Authors:  John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang
Journal:  Nat Rev Clin Oncol       Date:  2020-02-20       Impact factor: 66.675

9.  Factors influencing the risk of local recurrence after resection of a single brain metastasis.

Authors:  Akash J Patel; Dima Suki; Mustafa Aziz Hatiboglu; Hiba Abouassi; Weiming Shi; David M Wildrick; Frederick F Lang; Raymond Sawaya
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

10.  The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study.

Authors:  Laila Siam; Annalen Bleckmann; Han-Ning Chaung; Alexander Mohr; Florian Klemm; Alonso Barrantes-Freer; Raquel Blazquez; Hendrik A Wolff; Florian Lüke; Veit Rohde; Christine Stadelmann; Tobias Pukrop
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.